This confirms the neuroprotective role of TRPM2 inhibition in stroke and suggests that peptide-based uncoupling of TRPM2-NMDAR association is a promising therapeutic strategy for ischemic stroke (Wu and Tymianski, 2018; Zong et al., 2022b). Here, TRPM2 is linked to stroke disorder.